Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_assertion type Assertion NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_head.
- NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_assertion description "[In a xenograft mouse model of human PC, CDF treatment significantly inhibited tumor growth, which was associated with decreased NF-?B DNA binding activity, COX-2, and miR-21 expression, and increased PTEN and miR-200 expression in tumor remnants.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_provenance.
- NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_assertion evidence source_evidence_literature NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_provenance.
- NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_assertion SIO_000772 21408027 NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_provenance.
- NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_assertion wasDerivedFrom befree-20140225 NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_provenance.
- NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_assertion wasGeneratedBy ECO_0000203 NP792065.RAGy7EkBVAtoCsJEMKWB12t0wEit-N6-q4VOZdsUrEAV8130_provenance.